Pharmacy Decision Support Systems: Enhancing Clinical Decision-Making and Medication Safety
DOI:
https://doi.org/10.61841/9ya17x07Keywords:
Pharmacy Decision Support Systems, Clinical Decision-Making, Medication Safety, Healthcare TechnologyAbstract
Pharmacy Decision Support Systems (PDSS) have become integral tools in the field of healthcare, aimed at enhancing clinical decision-making and medication safety. This research paper explores the multifaceted role of PDSS in contemporary pharmacy practice and its impact on patient care. Through a comprehensive literature review and analysis, we delve into the benefits, challenges, and future prospects of these systems. As the complexity of healthcare continues to grow, the need for effective clinical decision-making tools becomes increasingly evident. PDSS offers healthcare practitioners a wealth of information, from drug-drug interactions to dosage recommendations, helping them make informed decisions at the point of care. Such systems not only aid in reducing medication errors but also contribute to better patient outcomes and overall quality of care. However, this paper does not overlook the challenges and limitations associated with the implementation and use of PDSS. Issues such as system integration, user acceptance, and data security are addressed to provide a comprehensive view of the landscape. To illustrate the practical applications of PDSS, we present case studies and examples that highlight successful implementations and showcase how these systems have positively impacted clinical practice. Looking forward, this paper discusses the future directions and trends in the field of pharmacy decision support systems, considering the ever-evolving healthcare environment and the potential influence of technological advancements. In conclusion, PDSS offers significant promise for enhancing clinical decision-making and medication safety in pharmacy practice. This paper underscores the importance of these systems in modern healthcare, emphasizing the need for continued research and innovation to maximize their potential.
Downloads
References
1. M. O’Connor and K. H. Bowles, “CLINICAL DECISION SUPPORT: IMPROVING CARE, IMPROVING OUTCOMES,” Innovation in Aging, vol. 1, no. suppl_1, pp. 1378–1378, Jun. 2017, doi:10.1093/geroni/igx004.5071.
2. “Improving clinical practice using clinical decision support systems,” Clinical Governance: An International Journal, vol. 11, no. 2, Apr. 2006, doi: 10.1108/cgij.2006.24811bae.002.
3. D. F. Sittig, A. Wright, and B. Middleton, “Clinical Decision Support: a 25 Year Retrospective and a 25 Year Vision,” Yearbook of Medical Informatics, vol. 25, no. S 01, pp. S103–S116, Aug. 2016, doi: 10.15265/iys-2016-s034.
4. “Dental implants with different neck designs and surfaces. A 3 year retrospective study,” Clinical Oral Implants Research, vol. 28, no. S14, pp. 25–25, Oct. 2017, doi: 10.1111/clr.24_13042.
5. E. H. Wiig and W. A. Secord, “Clinical Measurement and Assessment,” The ASHA Leader, vol. 11, no. 2, pp. 10–27, Feb. 2006, doi: 10.1044/leader.ftr4.11022006.10.
6. M. Alazzam, “Factors Influencing Medical Professional Adoption of Electronic Health Record in Jordan Hospital,” SSRN Electronic Journal, 2017, Published, doi: 10.2139/ssrn.3522883.
7. K. C. Narattharaksa and M. Speece, “Key Success Factors Behind Electronic Medical Record Adoption in Thailand,” SSRN Electronic Journal, 2014, Published, doi: 10.2139/ssrn.2619689.
8. P. J. Helmons, B. O. Suijkerbuijk, P. V. Nannan Panday, and J. G. Kosterink, “Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis,” Journal of the American Medical Informatics Association, vol. 22, no. 4, pp. 764–772, Feb. 2015, doi: 10.1093/jamia/ocu010.
9. K. N. N. Charoensri and M. Speece, “Key Success Factors Behind Electronic Medical Record Adoption in Thailand,” SSRN Electronic Journal, 2011, Published, doi: 10.2139/ssrn.1869483.
10. L. J. Lesko and C. V. Lagishetty, “Are We Getting the Best Return on Investment From Clinical Drug‐Drug Interaction Studies?,” The Journal of Clinical Pharmacology, vol. 56, no. 5, pp. 555–558, Dec. 2015, doi:10.1002/jcph.661.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
